Foresight Nanotech Institute Logo
Image of nano
 
Type: 
Foresight Lectures
Foresight Presents: "GENOGEN: Regenerating Skin for Life" Dr. Nancy Mize
31 May, 2012 (All day)
Ristorante Don Giovanni, 235 Castro Street, Mountain View, CA 94041

Foresight Presents: "GENOGEN: Regenerating Skin for Life"

Dr. Nancy Mize

Date/Time: Thursday, May 31, 2012, 6:30pm in PDT

Drinks/Dinner: 6:30pm, Talk: 7:30pm

RSVP: $40 via http://www.paypal.com/ to foresight@foresight.org

Location: Ristorante Don Giovanni

235 Castro Street, Mountain View, CA 94041

GENOGEN is developing products that activate resident skin stem cells to stimulate local areas of regeneration of skin naturally – the way children heal. GENOGEN’s first product is a re-purposed agent, currently FDA and EU approved and marketed, and used in humans for over 5 years, with significant utility in the aesthetics sector for treatment of aging skin. Localized skin delivery of the stem cell activator with a growth matrix activates local regeneration and repair in situ – with no stem cell isolation, no stem cell prep, no surgery, extraction or re-implantation – resulting in accelerated healing and young skin.

NANCY K MIZE, PhD, Scientist, Innovator, and CEO of GENOGEN Inc., has researched stem cell activators since 2000, and is the co-inventor on 11 issued patents. Dr. Mize served as the BioMarker Expert for Personalized Medicine at Pacific BioDevelopment, the Director of Protein Bioinformatics at Hyseq/Nuvelo, and Scientist, Drug Delivery Technologies at Alza Corporation. Dr. Mize holds a PhD from UCSF in Cell Biology in the department of Human Physiology, BS from UC Berkeley and has completed Postdoctoral studies at the European Molecular Biology Laboratory (EMBL), Heidelberg, and Genentech.

Donate Now

 

Foresight Programs

Join Now

 

 

Foresight materials on the Web are ©1986–2014 Foresight Institute. All rights reserved. Legal Notices.
Privacy Policy

Web site optimization by Netconcepts. Email marketing by gravityMail. Maintained by James B. Lewis Enterprises.